Polymyalgia rheumatica is one of the most common rheumatic inflammatory disorders in people older than 50 years characterized by aching and prolonged morning stiffness in the shoulder and pelvic girdle and neck.. Areas covered: In this review, we will focus on recent advances on the diagnosis and management of PMR. Expert commentary: Controversy exist whether PMR represent a single entity disease or is an umbrella term that comprises a clinical presentation common to a range of related conditions (polymyalgic syndrome). To date there are no specific diagnostic tests, and the diagnosis remains clinical, although ultrasonography, positron emission tomography scan and the recent ACR/EULAR classification criteria may help to confirm the clinical diagnosis. A step-wise process for the diagnosis of PMR has been proposed. Low-dose steroids are highly effective in the majority of patients and remain the mainstay of treatment, but relapses occur in about 50% of patients and glucocorticoid related adverse event are common. The steroid sparing effects of the immunosuppressive treatment evaluated to date are unclear.

Recent advances in the diagnosis and treatment of polymyalgia rheumatica / Muratore, Francesco; Pazzola, Giulia; Pipitone, Nicolò; Salvarani, Carlo. - In: EXPERT REVIEW OF CLINICAL IMMUNOLOGY. - ISSN 1744-8409. - 2016 Oct;12(10):(2016), pp. 1037-1045. [10.1080/1744666X.2016.1178572]

Recent advances in the diagnosis and treatment of polymyalgia rheumatica

MURATORE, Francesco;SALVARANI, CARLO
2016

Abstract

Polymyalgia rheumatica is one of the most common rheumatic inflammatory disorders in people older than 50 years characterized by aching and prolonged morning stiffness in the shoulder and pelvic girdle and neck.. Areas covered: In this review, we will focus on recent advances on the diagnosis and management of PMR. Expert commentary: Controversy exist whether PMR represent a single entity disease or is an umbrella term that comprises a clinical presentation common to a range of related conditions (polymyalgic syndrome). To date there are no specific diagnostic tests, and the diagnosis remains clinical, although ultrasonography, positron emission tomography scan and the recent ACR/EULAR classification criteria may help to confirm the clinical diagnosis. A step-wise process for the diagnosis of PMR has been proposed. Low-dose steroids are highly effective in the majority of patients and remain the mainstay of treatment, but relapses occur in about 50% of patients and glucocorticoid related adverse event are common. The steroid sparing effects of the immunosuppressive treatment evaluated to date are unclear.
2016
6-mag-2016
2016 Oct;12(10)
1037
1045
Recent advances in the diagnosis and treatment of polymyalgia rheumatica / Muratore, Francesco; Pazzola, Giulia; Pipitone, Nicolò; Salvarani, Carlo. - In: EXPERT REVIEW OF CLINICAL IMMUNOLOGY. - ISSN 1744-8409. - 2016 Oct;12(10):(2016), pp. 1037-1045. [10.1080/1744666X.2016.1178572]
Muratore, Francesco; Pazzola, Giulia; Pipitone, Nicolò; Salvarani, Carlo
File in questo prodotto:
File Dimensione Formato  
muratore2016.pdf

Accesso riservato

Tipologia: Versione pubblicata dall'editore
Dimensione 986.83 kB
Formato Adobe PDF
986.83 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1102760
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 12
  • ???jsp.display-item.citation.isi??? 10
social impact